Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Many congratulations to Susan and Jordan for this prestigious honour, recognising their contributions to structural and centrosome biology, respectively

The Royal Society © The Royal Society

Susan Lea is an internationally renowned structural biologist who has pioneered the use of mixed structural methods to study host-pathogen interactions and other medically important molecular pathways. Her laboratory uses and develops cutting-edge structural methods including cryo-electron microscopy and X-ray crystallography to define molecular mechanisms involved in health and disease states. Using these approaches, she has unpicked fundamental interactions that define an individual’s susceptibility to diseases such a bacterial meningitis, dysentery and typhi. Particular highlights include the recent determination of the molecular architecture of the bacterial flagellar motor, the prototypical biological machine.

Susan first joined the Dunn School as an Associate Professor in 2020, and was later appointed to the Chair of Microbiology in 2016. Since 2021 that Susan has been Chief of the Center for Structural Biology and Senior Investigator, National Cancer Institute, NIH Center for Cancer Research, Frederick, USA, although she still maintains a small team at the Dunn School. Other honours include membership of EMBO and the Academy of Medical Sciences.

Jordan Raff is an expert in centrosomes and cell division. Major discoveries by the Raff lab include the remarkable observation that flies lacking centrioles, centrosomes and cilia can proceed through most of development normally, changing the textbook view that centrioles/centrosomes are essential for mitosis. A systematic search for genes required for centriole/centrosome biogenesis led to the discovery that overexpressing a single gene (PLK4) amplifies centrosomes in most fly cells and predisposes them to tumours, suggesting a causative link between centrosome amplification and cancer. More recently, his team showed that just three proteins (Spd-2, Polo and Cnn) cooperate to form a scaffold that can potentially explain one of the great mysteries of centrosomes: how the two mitotic centrosomes in a cell always grow to the same size.

Read the full story on the Sir William Dunn School of Pathology website.

Similar stories

Com-COV vaccine study to research third dose booster options for 12-to-15-year-olds

Researchers running the University of Oxford-led Com-COV programme have launched a further study of COVID-19 vaccination schedules in young people aged 12 to 15 – with a focus on assessing different options for a third dose booster vaccination.

Population-scale study highlights ongoing risk of COVID-19 in some cancer patients despite vaccination

COVID-19 vaccination is effective in most cancer patients, but the level of protection against COVID-19 infection, hospitalisation and death offered by the vaccine is less than in the general population and vaccine effectiveness wanes more quickly.

New reporting guidelines developed to improve AI in healthcare settings

New reporting guidelines, jointly published in Nature Medicine and the BMJ by Oxford researchers, will ensure that early studies on using Artificial Intelligence (AI) to treat real patients will give researchers the information needed to develop AI systems safely and effectively.

Major boost for Oxford’s mission to counter future pandemic threats

The Moh Family Foundation has given a substantial gift to support the work of Oxford University’s Pandemic Sciences Institute, greatly strengthening its ability to identify and counter future pandemic threats and ensure equitable access to treatments and vaccines around the world.

Three NHSBT research units launch at University of Oxford

The NIHR has awarded three new Blood and Transplant Research Units (BTRUs) to the University of Oxford.